FDA approves MannKind’s Afrezza inhaled insulin for children with diabetes

FDA approves MannKind’s Afrezza inhaled insulin for children with diabetes

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.